Ss-31 shows promise in the treatment of many diseases including the following below: amyotrophiclateral sclerosis (als). Alzheimer’s disease. Glaucoma. Diabetes. Skeletal muscleweakness. Traumatic braininjury (tbi). Atherosclerosis. Heart failure with ischemiareperfusion. Kidney fibrosis. Friedreich ataxia.
Mitochondria play a vital role in cellular metabolism. Because of their widespread effects on cellular functions, mitochondrial dysfunction is implicated in a wide range of diseases. SS-31 has been shown to reverse mitochondrial dysfunction by obliterating damaging inflammatory agents such as free radical oxygen species (ROS).
SS-31 is very unique in its ability to cross the blood-brain barrier and highly concentrate within the inner membrane of the mitochondria (IMM). SS-31 shows promise in the treatment of many neurodegenerative and cognitive disorders such as amyotrophic lateral sclerosis (ALS), Alzheimer’s, Friedreich ataxia, and glaucoma.
Anti-aging research is investigating SS-31 for its ability to reverse mitochondrial dysfunction and premature cell death. The mitochondrial dysfunction theory of aging and the free radical theory of aging are intertwined and both would be addressed by the intracellular benefits of SS-31.